Lauren Giannetti Sferrazza, MSL Field Director at Adela, Inc., shared a post by Adela on LinkedIn, adding:
“Very excited to attend MHNCS 2026. What an amazing opportunity to learn from the leaders in Head and Neck Cancer Care.”
Quoting Adela‘s post:
“Lindsay Mateo, MBA, Lauren Giannetti Sferrazza MS, LGC, and Scott Bratman from Adela will be at the Multidisciplinary Head and Neck Cancers Symposium in Palm Desert, CA, February 19–21, 2026.
Attending MHNCS as well? Connect with us! We’d welcome the opportunity to meet during the symposium.
Head and neck cancers demand truly coordinated care, and we’re honored to support the community of surgeons, medical oncologists, radiation oncologists, pathologists, and researchers focused on improving outcomes for patients.
At Adela, we’re advancing diagnostics designed to provide options for earlier detection, with the goal of helping clinicians identify recurrence sooner and support more timely, informed decisions across the care journey.
Stop by Booth 25 to meet the team and learn more about how Adela’s MRD test may support patients with head and neck cancer.
We’re especially looking forward to hearing about the challenges you’re seeing in practice and exploring how better tools can help address real-world decision-making during surveillance.
See you there!”
Other articles featuring Head and Neck Cancer on OncoDaily.